Document is current

Article History

Received: 12 August 2025

Accepted: 1 April 2026

First Online: 9 April 2026

Declarations

:

: The study was approved by the Ethics Committee of Ma’anshan People’s Hospital (Ethics Committee Number: 2024-02-(04)), located at No. 45, Hubei Road, Ma’anshan City, Anhui Province, China. The study was also registered at the Chinese Clinical Trial Registry (website: ; registration number: ChiCTR 2500107208) and adhered to the principles of the Declaration of Helsinki. The first clinical trial registration was in 06/08/2025. An informed consent form designated specifically for the study was provided to each participant and explained in detail three days prior to the surgery.Participants could withdraw from the study unconditionally before the intervention. During the preoperative visit in the afternoon before the surgery, patients signed the written informed consent form.No changes to the study protocol, including eligibility criteria or outcome measures, occurred after the commencement of the trial.

: Not applicable.

: The authors declare no competing interests.